- Home
- / Annovis Bio
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Annovis Bio financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$9.8
2024-10-29
Market Capitalization
$127.3 M
2024-10-29
CreditSafe Score
?
Score changed on Jul 24, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 409.1K | 602.3K | 3.6M | 6.1M | 9.0M | 6.2M | 6.7M | 4.5M |
| Operating expense total | 682.4K | 713.9K | 6.6M | 25.5M | 45.0M | 26.7M | 29.7M | |
| EBIT | (682.4K) | (713.9K) | (6.6M) | (14.5M) | (25.5M) | (45.0M) | (26.7M) | |
| Interest income | 84.0 | 66.0 | 331.8K | 699.1K | ||||
| Interest expense | 47.2K | 13.3K | 182.7K | 667.9K | ||||
| Pre tax profit | (682.3K) | (713.9K) | (5.5M) | (14.5M) | (25.3M) | (56.2M) | ||
| Net Income | (682.3K) | (713.9K) | (5.5M) | (14.5M) | (25.3M) | (56.2M) | (24.6M) | (28.9M) |
| EPS | (3.1) | (6.2) | (2.3) | (1.4) |